Efficacy News and Research

RSS

Researchers detect positive COVID-19 cases in 20 minutes using blood samples

World-first research by Monash University in Australia has been able to detect positive COVID-19 cases using blood samples in about 20 minutes, and identify whether someone has contracted the virus.

17 Jul 2020

Advanced trials are needed to assess psychological therapies, say researchers

Various forms of psychotherapies have been shown to be efficacious and cost-effective for a wide spectrum of mental disorders.

17 Jul 2020

Findings show promise for developing vaccines against multiple strains of flu, including SARS-CoV-2

A vaccine additive known as an adjuvant can enhance responses to a vaccine containing the exotic avian flu virus H5N1, so that both rookie and veteran elements of the immune response are strengthened, according to results from an Emory Vaccine Center study.

17 Jul 2020

Advances in Alzheimer's drug development offer hope for patients

Dr. Jeffrey L. Cummings, UNLV research professor and a leading expert on Alzheimer's disease clinical trials, led a five-year review of all Alzheimer's drugs in the development pipeline. He says today there is more hope than ever that we'll one day solve Alzheimer's.

16 Jul 2020

American beautyberry leaf extract boosts antibiotic's activity against 'superbug'

Scientists discovered a compound in the leaves of a common shrub, the American beautyberry, that boosts an antibiotic's activity against antibiotic-resistant staph bacteria.

16 Jul 2020

Common blood test could advance life-saving treatment for heart failure

Biomedical experts believe that half of heart failure patients likely have low levels of the thyroid hormone T3 in their cardiac tissue.

16 Jul 2020

A new strategy to combat treatment resistance in choroidal neovascularization

An international team of researchers led by Baylor College of Medicine and Houston Methodist has discovered a strategy that can potentially address a major challenge to the current treatment for choroidal neovascularization (CNV), an aggressive form of age-related macular degeneration, the leading cause of irreversible blindness in the elderly.

16 Jul 2020

Inflammageing may be related to worse COVID-19 outcomes in older individuals

The increased severity and mortality of SARS-CoV-2 infections in older individuals may be related to inflammageing - an age-associated phenomenon of increased general inflammation.

16 Jul 2020

Study shows how radiotherapy alters the behavior of immune cells in glioblastoma tumors

A Ludwig Cancer Research study has dissected how radiotherapy alters the behavior of immune cells known as macrophages found in glioblastoma (GBM) tumors and shown how these cells might be reprogrammed with an existing drug to suppress the invariable recurrence of the aggressive brain cancer.

16 Jul 2020

Researchers design new model to predict life expectancy of patients with Creutzfeldt‐Jakob disease

Creutzfeldt-Jakob disease (CJD) is a serious minority neurodegenerative disease, with an annual rate of 1.5 cases per million inhabitants, which represents approximately 11 cases each year in Catalonia. CJD is a very rapid and fatal disease, in fact, the mean life expectancy is six months after diagnosis.

15 Jul 2020

States slow to implement social distancing measures saw higher COVID-19 mortality

As the COVID-19 pandemic spread across the United States, governments at the state and local levels issued emergency declarations and shut down schools.

15 Jul 2020

Study provides new insights into genetic susceptibility of COVID-19

A new Cleveland Clinic study has identified genetic factors that may influence susceptibility to COVID-19. Published today in BMC Medicine, the study findings could guide personalized treatment for COVID-19.

15 Jul 2020

UC study tests efficacy of immune regulating drug in treating patients with COVID-19 pneumonia

Researchers at the University of Cincinnati are testing a commonly used drug, called sirolimus, to determine its safety and efficacy in treating hospitalized patients with COVID-19 pneumonia in the trial.

15 Jul 2020

Individuals exposed to early life stress more likely to develop youth-onset depression

A study in the Journal of the American Academy of Child and Adolescent Psychiatry (JAACAP), published by Elsevier, reports that individuals exposed to early life stress (ELS) were more likely to develop a major depressive disorder (MDD) in childhood or adolescence than individuals who had not been exposed to ELS.

15 Jul 2020

NanoSurface Biomedical is now Curi Bio

NanoSurface Biomedical, a leading developer of human stem cell-based biotechnology products, today announced a comprehensive rebrand, including a change of the company’s name to Curi Bio.

From Curi Bio 15 Jul 2020

Experimental vaccine induces neutralizing antibodies against SARS-CoV-2

An investigational vaccine, mRNA-1273, designed to protect against SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), was generally well tolerated and prompted neutralizing antibody activity in healthy adults, according to interim results published online today in The New England Journal of Medicine.

15 Jul 2020

Strong evidence several FDA approved drugs block SARS-CoV-2 in relevant cell-lines and human organoids

Now, a new study describes how compounds that restore the normal transcriptional conditions following infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can be used to reduce viral load without neutralizing the virus entry into the host cell.

15 Jul 2020

Llama nanobodies block SARS-CoV-2 infection in vitro

Now, a team of scientists at the United Kingdom's Rosalind Franklin Institute may have a surprising solution for the coronavirus pandemic, which has killed more than 574,000 people worldwide.

14 Jul 2020

Umbilical cord blood safely and effectively treats children with rare genetic disorders

Researchers at UPMC Children's Hospital of Pittsburgh found that infusing umbilical cord blood - a readily available source of stem cells - safely and effectively treated 44 children born with various non-cancerous genetic disorders, including sickle cell, thalassemia, Hunter syndrome, Krabbe disease, metachromatic leukodystrophy (MLD) and an array of immune deficiencies.

14 Jul 2020

Keck Medicine of USC participates in clinical trial to evaluate antiviral drug as possible COVID-19 treatment

Keck Medicine of USC physicians are enrolling patients as part of an international clinical trial to evaluate the safety and efficacy of an antiviral drug, DAS181, as a possible treatment for hospitalized patients with severe COVID-19.

14 Jul 2020

Efficacy News and Research

Researchers detect positive COVID-19 cases in 20 minutes using blood samples

Advanced trials are needed to assess psychological therapies, say researchers

Findings show promise for developing vaccines against multiple strains of flu, including SARS-CoV-2

Advances in Alzheimer's drug development offer hope for patients

American beautyberry leaf extract boosts antibiotic's activity against 'superbug'

Common blood test could advance life-saving treatment for heart failure

A new strategy to combat treatment resistance in choroidal neovascularization

Inflammageing may be related to worse COVID-19 outcomes in older individuals

Study shows how radiotherapy alters the behavior of immune cells in glioblastoma tumors

Researchers design new model to predict life expectancy of patients with Creutzfeldt‐Jakob disease

States slow to implement social distancing measures saw higher COVID-19 mortality

Study provides new insights into genetic susceptibility of COVID-19

UC study tests efficacy of immune regulating drug in treating patients with COVID-19 pneumonia

Individuals exposed to early life stress more likely to develop youth-onset depression

NanoSurface Biomedical is now Curi Bio

Experimental vaccine induces neutralizing antibodies against SARS-CoV-2

Strong evidence several FDA approved drugs block SARS-CoV-2 in relevant cell-lines and human organoids

Llama nanobodies block SARS-CoV-2 infection in vitro

Umbilical cord blood safely and effectively treats children with rare genetic disorders

Keck Medicine of USC participates in clinical trial to evaluate antiviral drug as possible COVID-19 treatment

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News